VJHemOnc is committed to improving our service to you

COMy 2019 | Further evidence of the benefits of double auto-SCT

VJHemOnc is committed to improving our service to you

Michele Cavo

Here, Michele Cavo, MD, of Bologna University School of Medicine, Bologna, Italy, discusses a retrospective analysis of three previous European trials which compared bortezomib-based vs. non-bortezomib based transplant regimens for multiple myeloma. This supported the EMN02 trial (NCT01208766) data, which suggested that double transplants provided more benefits than single transplants. This interview was recorded at the Controversies in Multiple Myeloma (COMy) 2019 meeting held in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter